Clinical and paraclinical findings in natalizumab-associated infratentorial progressive multifocal leukoencephalopathy patients

J Neurol Neurosurg Psychiatry. 2014 Oct;85(10):1177-8. doi: 10.1136/jnnp-2014-307582. Epub 2014 Apr 3.

Authors

R Hoepner¹, J Ahlbrecht², S Faissner¹, R Schneider¹, S Dahlhaus¹, O Adams³, P Raab⁴, C Lukas⁵, A Chan¹, M Stangel², R Gold¹

Affiliations

¹ Department of Neurology, St. Josef Hospital Bochum, Ruhr University, Bochum, Germany.
² Department of Neurology, Hannover Medical School, Hannover, Germany.
³ Department of Virology, Heinrich Heine University Duesseldorf, Duesseldorf, Germany.
⁴ Institute of Diagnostic and Interventional Neuroradiology, Hannover Medical School, Hannover, Germany.
⁵ Institute of Diagnostic and Interventional Neuroradiology, St. Josef Hospital Bochum, Ruhr University, Bochum, Germany.

PMID: 24700881
DOI: 10.1136/jnnp-2014-307582

No abstract available

Keywords: Clinical Neurology; Multiple Sclerosis; Neurovirology.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Antibodies, Monoclonal, Humanized / adverse effects*
Antibodies, Monoclonal, Humanized / therapeutic use
Cerebellum / pathology*
Disease Progression
Female
Humans
Leukoencephalopathy, Progressive Multifocal / chemically induced*
Leukoencephalopathy, Progressive Multifocal / complications
Leukoencephalopathy, Progressive Multifocal / diagnosis*
Leukoencephalopathy, Progressive Multifocal / pathology
Magnetic Resonance Imaging
Male
Middle Aged
Multiple Sclerosis, Relapsing-Remitting / complications
Multiple Sclerosis, Relapsing-Remitting / drug therapy
Natalizumab
Pons / pathology
Retrospective Studies
Symptom Assessment

Substances

Antibodies, Monoclonal, Humanized
Natalizumab